L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP
Conditions: Severe Obesity; Type 2 Diabetes Mellitus in Obese Intervention: Other: Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells. Sponsor: University of Sao Paulo General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Eating Disorders & Weight Management | Endocrinology | Hospitals | Incretin Therapy | Obesity | Research